Karani Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$943K Sell
7,836
-2,384
-23% -$275K 0.77% 30
2025
Q4
$1.08M Sell
10,220
-1,019
-9% -$95.7K 0.88% 22
2025
Q3
$943K Sell
11,239
-202
-2% -$16.6K 0.75% 24
2025
Q2
$906K Sell
11,441
-1,164
-9% -$92.5K 0.88% 27
2025
Q1
$1.13M Sell
12,605
-29
-0.2% -$2.71K 1.2% 26
2024
Q4
$1.26M Buy
+12,634
New +$1.3M 1.17% 25
2023
Q3
$158K Buy
+1,536
New +$166K 0.23% 34

Other funds holding MRK

Karani Asset Management's MRK Position: Q1 2026 in Review

Karani Asset Management reduced its Merck (MRK) stake by 23% in Q1 2026, selling an estimated $275K and leaving 7,836 shares worth $943K. The position accounts for 0.77% of the portfolio, ranked #30.

Karani Asset Management first reported a position in MRK in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.26M in Q4 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Karani Asset Management held 7,836 shares of Merck worth $943K as of Q1 2026.
  • Karani Asset Management sold 2,384 Merck shares in Q1 2026, an estimated $275K.
  • Merck made up 0.77% of Karani Asset Management's portfolio in Q1 2026, its #30 holding.
  • Karani Asset Management first reported a position in Merck in Q3 2023 and has held it in 7 quarters since.
  • Karani Asset Management's Merck position peaked at $1.26M in Q4 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Karani Asset Management's 13F filing for Q1 2026, filed 15 May 2026.